Concerns about heart issues found to be inconsistent with review.
On Thursday, the board of advisors for the Centers for Disease Control and Prevention (CDC) unanimously voted to recommend Moderna’s COVID-19 vaccine for those aged 6 to 17. Though similar in structure and effectiveness to Pfizer’s vaccine for the same age range, there were some concerns that Moderna could negatively affect types of heart inflammation in younger males.
After reviewing the data, the advisors found that the statistically insignificant number of those found with such issues were likely random occurrences rather than the cause of the vaccination itself.
The federal government needs the recommendation to receive the approval of CDC Director Rochelle Walensky before officially sending out the vaccine to vaccination providers. She is expected to sign off on the recommendation.
As the Lord Leads, Pray with Us…
- For CDC officials as they review and assess medications, therapies, and vaccines.
- That CDC Director Walendsky would seek God’s guidance as she leads her agency.
Sources: Centers for Disease Control and Prevention, Reuters
